Trading Strategies

This Blue-Chip Firm Is Showing Us the "Fast Lane" to Cannabis Billions

The cannabis market is starting to soar.

The United States is a huge market opportunity, with market projections growing from an estimated $8.5 billion last year to $23.4 billion in 2022, if only a few additional states legalize recreational use. And we're talking about as much as $50 billion if most states follow the trend.

But the biggest opportunity of all could come in a form people hadn't been talking about as much…

It's an opportunity that runs counter to the recreational market trend and the obsession with the cannabinoid THC – the one that causes users to get "high." 

I'm talking about some of the other highly prized cannabinoids present in marijuana - one in particular that one of the world's biggest, most well-known companies has taken a sudden interest in...

Trading Strategies

Cash Runs to Quality in This Growing $1.5 Billion Cannabis Niche

Every investor should understand how the market for cannabis is developing – now and over the coming weeks, months, and years.

Choosing the companies best positioned to profit in the emerging market helps you gain an edge over those who simply "throw darts at a list of stocks" and pick cannabis companies without regard to industry realities.

But as legalization becomes more widespread throughout the United States and across the whole of Canada, investors still face questions about what the realities of a mature cannabis market might be.

For some answers, we can look at Colorado – the first U.S. state to make recreational cannabis easily available.

That made some realities evident.

We know, for example, that in places where vaporizing (aka "vaping") cannabis concentrate is legal, that form quickly takes over a significant part of the market.

Vaporizable concentrates are a value-added product, but they're also fairly commoditized, meaning customers shop by product attributes, such as how rigorously it's been tested, say, or the ratio of THC to CBD, as opposed to shopping by brand.

The traditional marijuana bud, or "flower," market, which in Canada is worth about $1.5 billion today, is still fragmented. Customers there are still experimenting with different strains, different growers and brands, and different cannabinoids and THC to CBD ratios. In other words, there are a lot of questions.

One big question facing the market – both in Colorado and worldwide – is whether consumers are willing to pay up for "super-premium" cannabis. That is, cannabis that is more expensive to produce… but that generates a better smoking experience.

There are many producers claiming to grow such cannabis – that's why it's such a big question. After all, no one is going to advertise that they make the lowest-end cannabis on the market any more than Busch admits that its beer is lower-end than a craft brewer's.

So how can an investor tell when a company is really producing super-premium cannabis… or merely claiming to grow it?

That's a very important question because, naturally, the investment case for the genuine super-premium product tends to be much stronger than it might be for the pretenders.

One company last week gave us the answer, loud and clear...

Marijuana Stocks

The 3 Best Pot Stocks to Buy to Profit from the Cannabis Oil Boom

You'll find the best pot stocks to buy in one of the fastest-growing segments of the marijuana industry – cannabis oils.

Marijuana companies like cannabis oils because they carry higher profit margins than the "flower" type of products that consumers have traditionally smoked.

With North American sales expected to explode from $7.3 billion in 2016 to $24.5 billion by 2021, pot stocks focused on cannabis oil represent a rare profit opportunity.

Here are your three best prospects...